HELIOS PHARMACEUTICALS

pharmaceutical and veterinary preparations, namely, biological response modifiers and antifibrotic agents, primarily for use as anti-infective agents for the prevention and/or treatment of bacterial, viral or fungal infections; treatment for abnormal proliferation of fibroblastic cells; antiproliferative agent for the treatment of cancer; treatment for allergic diseases such as atopic dermatitis, asthma, and allergic rhinitis; and treatment for inflammatory diseases